Related references
Note: Only part of the references are listed.Craving, Cue Reactivity, and Stimulus Control Among Early-Stage Young Smokers: Effects of Smoking Intensity and Gender
Matthew J. Carpenter et al.
NICOTINE & TOBACCO RESEARCH (2014)
Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey
Karin A. Kasza et al.
ADDICTION (2013)
Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy
Eva Kralikova et al.
ADDICTION (2013)
How does rate of smoking cessation vary by age, gender and social grade? Findings from a population survey in England
Jennifer Fidler et al.
ADDICTION (2013)
Gender Differences in Smoking Following an Implicit Mood Induction
Andrea H. Weinberger et al.
NICOTINE & TOBACCO RESEARCH (2012)
Systematic Biases in Cross-sectional Community Studies may Underestimate the Effectiveness of Stop-Smoking Medications
Ron Borland et al.
NICOTINE & TOBACCO RESEARCH (2012)
Gender Differences in Craving and Cue Reactivity to Smoking and Negative Affect/Stress Cues
Michael E. Saladin et al.
AMERICAN JOURNAL ON ADDICTIONS (2012)
Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion
Carolyn M. Mazure et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo
David Gonzales et al.
ADDICTION (2010)
Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: A retrospective analysis
Teresa R. Franklin et al.
JOURNAL OF WOMENS HEALTH (2008)
Sex differences in long-term smoking cessation rates due to nicotine patch
Kenneth A. Perkins et al.
NICOTINE & TOBACCO RESEARCH (2008)
Quit attempts and intention to quit cigarette smoking among young adults in United States
Pebbles Fagan et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2007)
Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation -: A randomized controlled trial
Douglas E. Jorenby et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Individual-level predictors of cessation behaviours among participants in the International Tobacco Control (ITC) Four Country Survey
A. Hyland et al.
TOBACCO CONTROL (2006)
Methods of the International Tobacco Control (ITC) Four Country Survey
M. E. Thompson et al.
TOBACCO CONTROL (2006)
The conceptual framework of the international tobacco control (ITC) policy evaluation project
G. T. Fong et al.
TOBACCO CONTROL (2006)
Perceived risks and benefits of smoking cessation: Gender-specific predictors of motivation and treatment outcome
SA McKee et al.
ADDICTIVE BEHAVIORS (2005)
Association between age, gender and reasons for smoking cessation
L Grotvedt et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2005)
Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling
BN Collins et al.
NICOTINE & TOBACCO RESEARCH (2004)
Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: Differences between men and women
A Cepeda-Benito et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2004)
Predictors of cessation in a cohort of current and former smokers followed over 13 years
A Hyland et al.
NICOTINE & TOBACCO RESEARCH (2004)
Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of Bupropion SR
D Scharf et al.
ADDICTION (2004)
Are there sex differences in transdermal nicotine replacement therapy patch efficacy?: A meta-analysis
M Munafò et al.
NICOTINE & TOBACCO RESEARCH (2004)
Gender differences in quit rates following smoking cessation with combination nicotine therapy: Influence of baseline smoking behavior
A Bohadana et al.
NICOTINE & TOBACCO RESEARCH (2003)
Share Paper
